Lead Product(s) : Lactoferrin
Therapeutic Area : Hematology
Study Phase : Undisclosed
Sponsor : Al-Azhar University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lactoferrin Alone ,Iron Alone Vs Lactoferrin Plus Iron for Treatment of Iron Deficiency Anemia
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
September 19, 2024
Lead Product(s) : Lactoferrin
Therapeutic Area : Hematology
Highest Development Status : Undisclosed
Sponsor : Al-Azhar University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactoferrin
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Glanbia Nutritionals
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Lactoferrin-enriched Whey on Iron Status in Females
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
January 31, 2024
Lead Product(s) : Lactoferrin
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Glanbia Nutritionals
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactoferrin
Therapeutic Area : Hematology
Study Phase : Undisclosed
Sponsor : Sir Run Run Shaw Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Lactoferrin Supplementation and Iron Metabolism in Healthy Pregnant Women
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
April 21, 2017
Lead Product(s) : Lactoferrin
Therapeutic Area : Hematology
Highest Development Status : Undisclosed
Sponsor : Sir Run Run Shaw Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactoferrin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Study of Yili Lactoferrin ShuHua Milk in the Improvement of Human Immunization
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
September 03, 2012
Lead Product(s) : Lactoferrin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactoferrin
Therapeutic Area : Gastroenterology
Study Phase : Phase III
Sponsor : National Institute on Aging
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
June 27, 2011
Lead Product(s) : Lactoferrin
Therapeutic Area : Gastroenterology
Highest Development Status : Phase III
Sponsor : National Institute on Aging
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactoferrin
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Efficacy Study of Oral XIGO Tablets to Treat The Common Cold
Details : Undisclosed
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
March 24, 2010
Lead Product(s) : Lactoferrin
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable